genprowebdirectory
GEN Edge
Latest News
Login
Subscribe
News
Insights
Trends for 2020
Trends for 2021
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Webinars/Virtual Events
eBooks
Podcasts
Tutorials
Peer-Reviewed Journals
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Create an account
Privacy Policy
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Latest News
Login
Subscribe
News
Financing
Zymergen CEO Quits, Shares Plunge 68% as Revenue Plans Derailed
Breast Cancer
New Therapy Targets Aggressive Chemotherapy-Resistant Breast Cancer
Cancer
Stem Cell Dormancy Could Hold the Key to Future Cancer Therapies
Antibacterials
Tuberculosis Essential Gene Index of Vulnerability Points to Promising, Underexplored Targets
CRISPR-Cas9
Modified RNA Guides Improve RNA Targeting Ability of CRISPR-Cas13
Insights
All
Trends for 2020
Trends for 2021
Antibodies
COG and Economies of Scale for Advanced Therapies
Bioprocessing
Why Biopharma Should Consider Plant-Based Manufacturing
Bioprocessing
Countering Complexity with Bioprocessing Systems
Antibodies
Artificial Intelligence Employed to Improve Antibody Quality
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
OMICs
Translational Medicine
A-Lists
A-Lists
Top 10 Synthetic Biology Companies
A-Lists
Seven Up-and-Coming COVID-19 Drugs
A-Lists
Top 8 Best-Selling COVID-19 Vaccines and Drugs of Q1 2021
A-Lists
Top 10 Life Sciences Jobs Most in Demand over the Next…
A-Lists
Top 10 U.S. Biopharma Clusters
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Webinars/Virtual Events
eBooks
Podcasts
Tutorials
Peer-Reviewed Journals
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Drug Discovery
ADME/TOX
ADME/TOX
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
ADME/TOX
Organs-on-Chips a Step Closer to Reality
ADME/TOX
Agilent to Establish New Research Center at Seoul National University
ADME/TOX
EA Wins $27M EPA Contract Renewal
ADME/TOX
The Hamner to Develop 3-D Liver Bioassays
ADME/TOX
AstraZeneca to Use Wyss Institute’s Organs-on-Chips
ADME/TOX
Promega and Celsis to Provide Solutions for ADME/Tox Testing in Primary...
ADME/TOX
AstraZeneca to Use Wyss Institute’s Organs-on-Chips
ADME/TOX
Heart-on-a-Chip Gets Drug Screeners Pumped
ADME/TOX
CIT Joins European Consortium Focusing on Improving Toxicity Testing
ADME/TOX
Agilent to Establish New Research Center at Seoul National University
ADME/TOX
Organs-on-Chips a Step Closer to Reality
ADME/TOX
Scientists Find Link Between ARB Therapy and Cancer
ADME/TOX
AZ Looks to Charles River Labs for In Vivo Biology
ADME/TOX
Qiagen Expands Partnership with Genome Diagnostics for Development of Six New...
ADME/TOX
FDA Lifts Clinical Hold on Proellex to Allow Escalating Low-Dose Safety...
1
2
3
...
7
Page 1 of 7
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
![Automated C-Path system developed by Stanford researchers takes thousands of measurements not currently used to grade breast cancer tumors.[© Sebastian Kaulitzki - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/Nov10_2011_21425225_BreastCancerBlackWhiteIllustration_BreastCancerBresearch1372410755-218x150.jpg "New Therapy Targets Aggressive Chemotherapy-Resistant Breast Cancer")
![Heart-on-a-chip uses human cardiac muscle cells derived from adult stem cells to assess drugs’ cardiotoxicity. [Anurag Mathur/Healy Lab]](https://www.genengnews.com/wp-content/uploads/2018/08/Mar9_2015_HealyLab_HeartChip4196107801-324x160.jpg "Heart-on-a-Chip Gets Drug Screeners Pumped")
![Research appearing in The Lancet Oncology suggests that those receiving one year of treatment have a 1.2% risk. [© David G - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/June14_4377221_PillsOnCardiogram_ARBsCauseCancer_Omics1442022161-324x160.jpg "Scientists Find Link Between ARB Therapy and Cancer")
